Variations of very low-density lipoprotein receptor subtype expression in gastrointestinal adenocarcinoma cells with various differentiations

World Journal of Gastroenterology

Volumn 11, Issue 18, 2005, Pages 2817-2822

  Chen, Tao ^a   Wu, Fan ^a   Chen, Feng Ming ^b   Tian, Jun ^a   Qu, Shen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Gastric adenocarcinoma; VLDLR

Indexed keywords

VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; CANCER GROWTH; CELL DIFFERENTIATION; CELL LINE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; GASTROINTESTINAL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOGENESIS; WESTERN BLOTTING;

EID: 18944401740     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i18.2817     Document Type: Article

References (32)

1. Liu ZG, Qu S, Feng N, Zong YQ, Deng YZ, Feng ZC. Effects of induced deletion of repeats in binding domain of the VLDL receptor on its ligand-binding capacity. Shengwu Huaxue Yushengwuwuli Xuebao 2002; 34: 158-164
2. Takahashi S, Kawarabayashi Y, Nakai J, Sakai J, Yamamoto T. Rabbit very lowdensity lipoprotein receptor: a low-density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci USA 1992; 89: 9252-9256
3. Sakai J, Hoshino A, Takahashi S, Miura Y, Ishii H, Suzuki H, Kawarabayasi Y, Yamamoto T. Structure, chromosome location, and expression of the human very low-density lipoprotein receptor gene. J Biol Chem 1994; 269: 2173-2182
4. Lijima H, Miyazawa M, Sakai J, Magoori K, Ito MR, Suzuki H, Nose M, Kawarabayasi Y, Yamamoto TT. Expression and characterization of a very low density lipoprotein receptor variant lacking the O-linked sugar region generated by alternative splicing. J Biochem 1998; 124: 747-755
5. Webb JC, Patel DD, Jones MD, Knight BL, Soutar AK. Characterization and tissue-specific expression of the human 'very low density lipoprotein (VLDL) receptor' mRNA. Hum Mol Genet 1994; 3: 531-537
6. Tiebel O, Oka K, Robinson K, Sullivan M, Martinez J, Nakamuta M, Ishimura-Oka K, Chan L. Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation. Atherosclerosis 1999; 145: 239-251
7. Yagyu H, Lutz EP, Kako Y, Marks S, Hu Y, Choi SY, Bensadoun A, Goldberg IJ. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J Biol Chem 2002; 277: 10037-10043
8. Elkin RG, Zhong Y. Assessment of reproductive function in mutant restricted ovulator carrier roosters. Poult Sci 2002; 81: 1280-1282
9. Hermann M, Mahon MG, Lindstedt KA, Nimpf J, Schneider WJ. Lipoprotein receptors in extraembryonic tissues of the chicken. J Biol Chem 2000; 275: 16837-16844
10. r 40 000 receptor associated protein. FEBS Lett 1994; 354: 279-283
11. r 40 000 receptor-associated protein. Eur J Biochem 1997; 248: 583-591
12. Gafvels ME, Caird M, Britt D, Jackson CL, Patterson D. Strauss JF 3rd. Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9 pter-p23. Somat Cell Mol Genet 1993; 19: 557-569
13. Shen Q, Tao C, Fan W, Yanhua Y, Hao B. Preparation and characterization of polyclonal antibodies against VLDL receptor. J Huazhong Univ Sci Technolog Med Sci 2004; 24: 205-207
14. Nakamura Y, Yamamoto M, Kumamaru E. Very low-density lipoprotein receptor in fetal intestine and gastric adenocarcinoma cells. Arch Pathol Lab Med 2000; 124: 119-122
15. May P, Bock HH, Nimpf J, Herz J. Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase. J Biol Chem 2003; 278: 37386-37392
16. Magrane J, Casaroli-Marano RP, Reina M, Gafvels M, Vilaro S. The role of O-linked sugars in determining the very low density lipoprotein receptor stability or release from the cell. FEBS Lett 1999; 451: 56-62
17. Nykjaer A, Willnow TE. The low-density lipoprotein receptor gene family: a cellular Swiss army knife? Trends Cell Biol 2002; 12: 273-280
18. Howell BW, Herz J. The LDL receptor gene family: signaling functions during development. Curr Opin Neurobiol 2001; 11: 74-81
19. Strickland DK, Gonias SL, Argraves WS. Diverse roles for the LDL receptor family. Trends Endocrinol Metab 2002; 13: 66-74
20. Nakamura Y, Yamamoto M, Kumamaru E. Significance of the variant and full-length forms of the very low density lipoprotein receptor in brain. Brain Res 2001; 922: 209-215
21. Nakamura Y, Yamamoto M, Kumamaru E. A variant very low density lipoprotein receptor lacking 84 base pairs of O-linked sugar domain in the human brain myelin. Brain Res 1998; 793: 47-53
22. Deguchi K, Inoue K, Avila WE, Lopez-Terrada D, Antalffy BA, Quattrocchi CC, Sheldon M, Mikoshiba K, D'Arcanglo G, Armstrong DL. Reelin and disabled-1 expression in developing and mature human cortical neurons. J Neuropathol Exp Neurol 2003; 62: 676-684
23. Homayouni R, Magdaleno S, Keshvara L, Rice DS, Curran T. Interaction of Disabled-1 and the GTPase activating protein Dab2IP in mouse brain. Brain Res Mol Brain Res 2003; 115: 121-129
24. Ensler K, Mohammadieh M, Broijersen A, Angelin B, Gafvels M. Dexamethasone stimulates very low density lipoprotein (VLDL) receptor gene expression in differentiating 3T3-L1 cells. Biochim Biophys Acta 2002; 1581: 36-48
25. Yang G, Bao L, Zhao J, Qu S. Investigation of the distribution and changes of VLDLR subtype in fibrotic cardiac muscles. J Tongji Med Univ 2000; 20: 297-300
26. Argraves KM, Battey FD, MacCalman CD, McCrae KR, Gafvels M, Kozarsky KF, Chappell DA, Strauss JF III, Strickland DK. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes. J Biol Chem 1995; 270: 26550-26557
27. Heegaard CW, Simonsen AC, Oka K, Kjoller L, Christensen A, Madsen B, Ellgaard L, Chan L, Andreasen PA. Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex. J Biol Chem 1995; 270: 20855-20861
28. Webb DJ, Nguyen DH, Sankovic M, Gonias SL. The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro. J Biol Chem 1999; 274: 7412-7420
29. Webb DJ, Thomas KS, Gonias SL. Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth. J Cell Biol 2001; 152: 741-752
30. Hembrough TA, Ruiz JF, Papathanassiu AE, Green SJ, Strickland DK. Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor. J Biol Chem 2001; 276: 12241-12248
31. Hembrough TA, Ruiz JF, Swerdlow BM, Swartz GM, Hammers HJ, Zhang L, Plum SM, Williams MS, Strickland DK, Pribluda VS. Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity. Blood 2004; 103: 3374-3380
32. Shirotani-Ikejima H, Kokame K, Hamuro T, Bu G, Kato H, Miyata T. Tissue factor pathway inhibitor induces expression of JUNB and GADD45B mRNAs. Biochem Biophys Res Commun 2002; 299: 847-852